m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00641)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
hsa-miR-1915-3p
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | hsa-miR-1915-3p expression was regulated by METTL3/YTHDF2 m6A axis through transcription factor KLF4. miR-1915-3p function as a tumor suppressor by targeting SET and has an anti-metastatic therapeutic potential for lung cancer treatment. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Non-small-cell lung carcinoma | ICD-11: 2C25.Y | ||
Pathway Response | TNF signaling pathway | hsa04668 | ||
Cell Process | Cell migration | |||
Cell invasion | ||||
Epithelial-mesenchymal transition | ||||
In-vitro Model | NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
YTH domain-containing family protein 2 (YTHDF2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | hsa-miR-1915-3p expression was regulated by METTL3/YTHDF2 m6A axis through transcription factor KLF4. miR-1915-3p function as a tumor suppressor by targeting SET and has an anti-metastatic therapeutic potential for lung cancer treatment. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Non-small-cell lung carcinoma | ICD-11: 2C25.Y | ||
Pathway Response | TNF signaling pathway | hsa04668 | ||
Cell Process | Cell migration | |||
Cell invasion | ||||
Epithelial-mesenchymal transition | ||||
In-vitro Model | NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
Lung cancer [ICD-11: 2C25]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | hsa-miR-1915-3p expression was regulated by METTL3/YTHDF2 m6A axis through transcription factor KLF4. miR-1915-3p function as a tumor suppressor by targeting SET and has an anti-metastatic therapeutic potential for lung cancer treatment. | |||
Responsed Disease | Non-small-cell lung carcinoma [ICD-11: 2C25.Y] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | TNF signaling pathway | hsa04668 | ||
Cell Process | Cell migration | |||
Cell invasion | ||||
Epithelial-mesenchymal transition | ||||
In-vitro Model | NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | hsa-miR-1915-3p expression was regulated by METTL3/YTHDF2 m6A axis through transcription factor KLF4. miR-1915-3p function as a tumor suppressor by targeting SET and has an anti-metastatic therapeutic potential for lung cancer treatment. | |||
Responsed Disease | Non-small-cell lung carcinoma [ICD-11: 2C25.Y] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Down regulation | |||
Pathway Response | TNF signaling pathway | hsa04668 | ||
Cell Process | Cell migration | |||
Cell invasion | ||||
Epithelial-mesenchymal transition | ||||
In-vitro Model | NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |